BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Institute of Oncology
X-ORIGINAL-URL:https://www.bricbordeaux.com/en/
X-WR-CALDESC:Events for Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230116
DTEND;VALUE=DATE:20230117
DTSTAMP:20230126T165547Z
CREATED:20230126T164520Z
LAST-MODIFIED:20230126T165547Z
UID:42481-1673827200-1673913599@www.bricbordeaux.com
SUMMARY:Oncosphere International Congress - BRIC participations
DESCRIPTION:The international congress of the Oncosphere was held on January 12 and 13\, 2023 in Bordeaux gathering more than 250 scientists around cancer research. Many scientists from our unit presented their work or participated in the moderation of the sessions. \nCongratulations to Camille Dantzer\, PhD student in team 3 who won the prize for the best flash-posters! \nhttps://oncospheremeeting.com/ \nThese two days of congress will be available soon in replay. Thanks to Oncosphere Nouvelle-Aquitaine and its supporters for the organization of this conference rich in exchanges.
URL:https://www.bricbordeaux.com/en/event/oncosphere-international-congress-bric-participations/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/01/image-en-avant.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230119
DTEND;VALUE=DATE:20230120
DTSTAMP:20230202T155034Z
CREATED:20230202T143819Z
LAST-MODIFIED:20230202T155034Z
UID:42549-1674086400-1674172799@www.bricbordeaux.com
SUMMARY:Focus of the SBM Department on Lucie Brisson and Thomas Mathivet
DESCRIPTION:In the last newsletter of the Department of Biological and Medical Sciences of the University of Bordeaux :\n👉Presentation of Lucie Brisson and Thomas Mathivet\, two Inserm CRs\, co-leaders of team 01 (Tumor and Vascular Biology Laboratory) and recently recruited in our U1312-BRIC unit
URL:https://www.bricbordeaux.com/en/event/focus-of-the-sbm-department-on-lucie-brisson-and-thomas-mathivet/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/lucie-brisson-et-thomas-mathivet.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230120
DTEND;VALUE=DATE:20230121
DTSTAMP:20230206T153018Z
CREATED:20230206T153018Z
LAST-MODIFIED:20230206T153018Z
UID:42584-1674172800-1674259199@www.bricbordeaux.com
SUMMARY:Figaro article - CRISPR - F. Moreau-Gaudry and A. bedel intervention
DESCRIPTION:Pr François Moreau-Gaudry and Dr Aurélie Bedel of Team 8 – Genetic Biotherapies and Oncology (BioGO)\, specialists in the study of genotoxicity induced by CRISPR-Cas9 testify in the Figaro article of 20/01/2023 on CRISPR technology.\n\n“The CRISPR revolution keeps its promises“\, headlines Le Figaro. Ten years after its discovery\, the genome editing tool has opened up exciting prospects for medicine. « The applications of CRISPR are too numerous to list extensively »\,notes American Jennifer Doudna\, a professor at the University of California\, Berkeley\, who developed the technique with Frenchwoman Emmanuelle Charpentier\, director of the Max Planck Research Center for Pathogen Science in Berlin. Jennifer Doudna publishes an article in the journal Science reviewing the last ten years of CRISPR-Cas9 technology. But as with any medical innovation\, however exciting it may be\, there are undesirable effects to be feared\, or at least monitored. This is the expertise developed by the Inserm team of Prof. François Moreau-Gaudry and Dr. Aurélie Bedel (U1312 Biotherapies of genetic diseases and cancers) at the University of Bordeaux. « Very quickly\, it was observed that CRISPR was less precise than expected: this is called the ‘off-target’ effect\, i.e. the scissors sometimes hit the wrong target or cause changes in the chromosome\,» explains Prof. Moreau-Gaudry. « This is of concern to us because these are molecular events that are found in cancer »\, explains Aurélie Bedel. This does not imply the suspension of ongoing trials\, she adds.\nExtract from the Inserm press review of 20/01\n\n\nLink to the online article.\nLink to the pdf of the article.\nBioGO team page.
URL:https://www.bricbordeaux.com/en/event/figaro-article-crispr-f-moreau-gaudry-and-a-bedel-intervention/
CATEGORIES:News
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2023/02/figaro-20-01-2023-crispr.jpg
END:VEVENT
END:VCALENDAR